98%
921
2 minutes
20
The emergence of linezolid-resistant Enterococcus spp. (LRE) due to transferable resistance determinants is a matter of concern. To understand the contribution of the plasmid-encoded optrA and poxtA genes to the emergence of LRE, clinical isolates from different Spanish hospitals submitted to the Spanish Reference Laboratory from 2015-2018 were analysed. Linezolid resistance mechanisms were screened in all isolates by PCR and sequencing. Genetic relatedness of Enterococcus spp. carrying optrA and poxtA was studied by PFGE and MLST. Antimicrobial susceptibility was tested by broth microdilution using EUCAST standards. A total of 97 LRE isolates were studied, in 94 (96.9%) of which at least one resistance determinant was detected; 84/97 isolates (86.6%) presented a single resistance mechanism as follows: 45/84 (53.6%) carried the optrA gene, 38/84 (45.2%) carried the G2576T mutation and 1/84 (1.2%) carried the poxtA gene. In addition, 5/97 isolates (5.2%) carried both optrA and the G2576T mutation and 5/97 (5.2%) carried both optrA and poxtA. The optrA gene was more frequent in Enterococcus faecalis (83.6%) than Enterococcus faecium (11.1%) and was mainly associated with community-acquired urinary tract infections. Carriage of the poxtA gene was more frequent in E. faecium (13.9%) than E. faecalis (1.6%). Among the optrA-positive E. faecalis isolates, two main clusters were detected by PFGE. These two clusters belonged to ST585 and ST480 and were distributed throughout 11 and 6 Spanish provinces, respectively. This is the first description of LRE carrying the poxtA gene in Spain, including the co-existence of optrA and poxtA in five isolates.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijantimicag.2020.105977 | DOI Listing |
BMC Infect Dis
August 2025
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China.
Background: Immunocompromised cancer patients represent a susceptible population for enterococcal infections. While linezolid remains the primary therapeutic option for vancomycin-resistant Enterococcus (VRE) infections, the emergence of linezolid-resistant Enterococcus (LRE) worldwide has not only exacerbated public health risks but also posed significant challenges to clinical treatment. This study aimed to analyze the prevalence of LRE isolates among cancer patients in China and to investigate the mechanisms of linezolid resistance.
View Article and Find Full Text PDFAccess Microbiol
April 2025
Laboratory of Food Microbiology and Food Safety, Department of Health and Environmental Sciences, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, 069-8501, Hokkaido, Japan.
Mobile linezolid-resistance genes (, and ) that confer resistance to linezolid and florfenicol have been detected globally in various sources. Linezolid is a last-resort antimicrobial used in human clinical settings, and florfenicol is commonly used in veterinary clinical settings. The present study sought to evaluate the potential of florfenicol in veterinary use to select for linezolid-resistant bacteria.
View Article and Find Full Text PDFInfect Drug Resist
June 2025
Department of Clinical Laboratory, Xijing Hospital, Air Force Medical University, Xi'an, Shanxi, 710032, People's Republic of China.
Purpose: This study examines the distribution of pathogens and the characteristics of linezolid-resistant (LRSA) in osteoarticular infections (OAIs) over an 11-year period.
Methods: Identification and initial antimicrobial susceptibility testing were conducted using the VITEK2 compact system. Broth microdilution method (BMD) to confirm linezolid-resistant isolates.
Front Microbiol
May 2025
College of Animal Science and Technology, Jilin Agricultural Science and Technology University, Jilin, China.
Jilin province is the primary region for dairy cow and milk production in China. However, there are few reports on the genetic characteristics, antibiotic resistance, and prevalence of () in raw milk. Between 2021 and 2022, researchers identified 214 strains, with a prevalence rate of 42.
View Article and Find Full Text PDFJAC Antimicrob Resist
June 2025
Department of Infection Control Science, Showa Medical University Graduate School of Pharmacy, Shinagawa, Tokyo, Japan.
Objectives: Studies combining linezolid resistance mechanisms and tedizolid susceptibility in linezolid-resistant clinical isolates are scarce. This study investigated the linezolid resistance mechanisms and tedizolid susceptibility of linezolid-resistant strains isolated clinically in Japan.
Methods: We analysed 25 linezolid-resistant strains of and isolated from Japanese hospitals between 2015 and 2021.